87 related articles for article (PubMed ID: 35309940)
1. Comprehensive Analysis of TRP Channel-Related Genes for Estimating the Immune Microenvironment, Prognosis, and Therapeutic Effect in Patients With Esophageal Squamous Cell Carcinoma.
Zhao F; Gao S; Qin X; Niu R; Li Z; Wang C; Li S
Front Cell Dev Biol; 2022; 10():820870. PubMed ID: 35309940
[TBL] [Abstract][Full Text] [Related]
2. Identification of a Prognostic Gene Signature Based on Lipid Metabolism-Related Genes in Esophageal Squamous Cell Carcinoma.
Shen GY; Yang PJ; Zhang WS; Chen JB; Tian QY; Zhang Y; Han B
Pharmgenomics Pers Med; 2023; 16():959-972. PubMed ID: 38023824
[TBL] [Abstract][Full Text] [Related]
3. Head and neck squamous cell carcinoma-specific prognostic signature and drug sensitive subtypes based on programmed cell death-related genes.
Xu C; Xu H; Liu B
PeerJ; 2023; 11():e16364. PubMed ID: 38025757
[TBL] [Abstract][Full Text] [Related]
4. Risk model based on genes regulating the response of tumor cells to T-cell-mediated killing in esophageal squamous cell carcinoma.
Zhang X; Yu C; Zhou S; Zhang Y; Tian B; Bian Y; Wang W; Lin H; Wang LW
Aging (Albany NY); 2024 Feb; 16(3):2494-2516. PubMed ID: 38305770
[TBL] [Abstract][Full Text] [Related]
5. A programmed cell death-related gene signature to predict prognosis and therapeutic responses in liver hepatocellular carcinoma.
Gu X; Pan J; Li Y; Feng L
Discov Oncol; 2024 Mar; 15(1):71. PubMed ID: 38466483
[TBL] [Abstract][Full Text] [Related]
6. Identification of prognostic value of anoikis-related gene score model combined with tumor microenvironment score models in esophageal squamous cell carcinoma.
Zhang M; Liang Y; Song P
J Gene Med; 2024 Jan; 26(1):e3624. PubMed ID: 38087999
[TBL] [Abstract][Full Text] [Related]
7. A Tumor Progression Related 7-Gene Signature Indicates Prognosis and Tumor Immune Characteristics of Gastric Cancer.
Liu F; Yang Z; Zheng L; Shao W; Cui X; Wang Y; Jia J; Fu Y
Front Oncol; 2021; 11():690129. PubMed ID: 34195091
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and immunological role of cancer-associated fibroblasts-derived exosomal protein in esophageal squamous cell carcinoma.
Wang Z; Zhang M; Liu L; Yang Y; Qiu J; Yu Y; Li J
Int Immunopharmacol; 2023 Nov; 124(Pt A):110837. PubMed ID: 37634448
[TBL] [Abstract][Full Text] [Related]
9. Development of a TLR-Based Model That Can Predict Prognosis, Tumor Microenvironment, and Drug Response for Esophageal Squamous Cell Carcinoma.
Cheng T; Huang X; Yang H; Gu J; Lu C; Zhan C; Xu F; Ge D
Biochem Genet; 2024 Jan; ():. PubMed ID: 38206423
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Prognostic Immune Signature for Esophageal Squamous Cell Carcinoma to Predict Survival and Inflammatory Landscapes.
Zhang C; Luo Y; Zhang Z; Zhang Z; Zhang G; Wang F; Che Y; Fang L; Zhang Y; Sun N; He J
Front Cell Dev Biol; 2020; 8():580005. PubMed ID: 33392181
[TBL] [Abstract][Full Text] [Related]
11. A novel tumor microenvironment-related gene signature with immune features for prognosis of lung squamous cell carcinoma.
Han WJ; He P
J Cancer Res Clin Oncol; 2023 Nov; 149(14):13137-13154. PubMed ID: 37479755
[TBL] [Abstract][Full Text] [Related]
12. Identification of Molecular Subtypes and Prognostic Characteristics of Adrenocortical Carcinoma Based on Unsupervised Clustering.
Zhang Y; Zhang C; Li K; Deng J; Liu H; Lai G; Xie B; Zhong X
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895143
[TBL] [Abstract][Full Text] [Related]
13. A SARS-CoV-2 related signature that explores the tumor microenvironment and predicts immunotherapy response in esophageal squamous cell cancer.
Ren Q; Zhang P; Zhang S; Chen W; Chi H; Wang W; Zhang W; Lin H; Yu Y
Aging (Albany NY); 2023 Oct; 15(19):10501-10523. PubMed ID: 37812215
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance and immune infiltration analyses of a novel coagulation-related signature in ovarian cancer.
Yang J; Wang C; Zhang Y; Cheng S; Wu M; Gu S; Xu S; Wu Y; Sheng J; Voon DC; Wang Y
Cancer Cell Int; 2023 Oct; 23(1):232. PubMed ID: 37803446
[TBL] [Abstract][Full Text] [Related]
15. Identification of molecular subtypes and prognostic signatures based on transient receptor potential channel-related genes to predict the prognostic risk of hepatocellular carcinoma: A review.
Wu D; Cai Q; Liu D; Zuo G; Li S; Liu L; Zheng J
Medicine (Baltimore); 2023 Mar; 102(10):e33228. PubMed ID: 36897679
[TBL] [Abstract][Full Text] [Related]
16. T cell-mediated tumor killing based signature to predict the prognosis and immunotherapy for glioblastoma.
Liu H; Shi K; Wei Z; Zhang Y; Li J
Heliyon; 2024 May; 10(10):e31207. PubMed ID: 38813229
[TBL] [Abstract][Full Text] [Related]
17. Identification of glycosyltransferase-related genes signature and integrative analyses in patients with ovarian cancer.
Zhang Y; Zhou T; Tang Q; Feng B; Liang Y
Am J Clin Exp Immunol; 2024; 13(1):12-25. PubMed ID: 38496354
[TBL] [Abstract][Full Text] [Related]
18. Deciphering Treg cell roles in esophageal squamous cell carcinoma: a comprehensive prognostic and immunotherapeutic analysis.
Zhang P; Dong S; Sun W; Zhong W; Xiong J; Gong X; Li J; Lin H; Zhuang Y
Front Mol Biosci; 2023; 10():1277530. PubMed ID: 37842637
[No Abstract] [Full Text] [Related]
19. Transient receptor potential channels' genes forecast cervical cancer outcomes and illuminate its impact on tumor cells.
Jiang S; Lin X; Wu Q; Zheng J; Cui Z; Cai X; Li Y; Zheng C; Sun Y
Front Genet; 2024; 15():1391842. PubMed ID: 38784033
[No Abstract] [Full Text] [Related]
20. A novel mitochondrial metabolism-related gene signature for predicting the prognosis of oesophageal squamous cell carcinoma.
Lin W; Ye C; Sun L; Chen Z; Qu C; Zhu M; Li J; Kong R; Xu Z
Aging (Albany NY); 2024 Jun; 16():. PubMed ID: 38843392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]